Views: 78 Author: Site Editor Publish Time: 2026-05-06 Origin: Site
Recently, Jiangsu Hanyoo Pharmatech Co., Ltd., a one-stop solid preparation equipment manufacturer, successfully participated in the 30th Tashkent International Healthcare Exhibition (TIHE 2026) in Tashkent, Uzbekistan.
As a key event in Central Asia’s pharmaceutical industry, TIHE 2026 gathered global industry players, providing a platform for displaying products and exploring cooperation.
During the exhibition, our company showcased our solid preparation equipment advantages and had in-depth exchanges with local partners. Uzbekistan has great market potential for pharmaceutical equipment, with favorable policies supporting international cooperation.
Our participation in TIHE 2026 achieved fruitful results. We established in-depth cooperative intentions with more than 20 local and regional partners, including potential distributors and joint venture partners, laying a solid foundation for our future market expansion in Uzbekistan and Central Asia. We also had in-depth exchanges with leading international enterprises such as Roche, Pfizer, and GSK, as well as local giants like UzDravFarm, gaining a clearer understanding of the competitive pattern and market demands in the region. It is worth noting that Uzbekistan has set a goal to increase the local production ratio of drugs to 70% by 2029, focusing on generic drugs, APIs, and biological products, which provides broad cooperation space for our team in technology transfer and joint production.
The exhibition also allowed us to deeply perceive the development trends of the Uzbekistan pharmaceutical market. With the aging population, rising incidence of chronic diseases, and increasing public health awareness, the demand for cardiovascular drugs, antibiotics, and Chinese medicine is growing rapidly. Meanwhile, the government’s promotion of digital transformation in the medical and health sector, including the construction of electronic health record systems and the popularization of portable diagnostic equipment, has brought new development opportunities for related pharmaceutical and medical device enterprises. As a country along the “Silk Road”, Uzbekistan also serves as a strategic gateway to the Central Asian market, radiating Kazakhstan, Turkmenistan, and other neighboring countries, which is of great significance for our team to expand its global layout.
Looking ahead, we will take this exhibition as an opportunity to fully leverage the policy dividends and market potential of Uzbekistan, further deepen cooperation with local partners, and tailor products and services to meet the specific needs of the region. We will actively participate in the localization construction of Uzbekistan’s pharmaceutical industry, contribute our professional strength to improving the accessibility of medical resources and promoting the high-quality development of the pharmaceutical industry in Central Asia, and strive to achieve mutual benefit and win-win results with all partners in the industry.
We would like to extend our sincere gratitude to the organizers of TIHE 2026, all partners we met during the exhibition, and our team for their hard work. We look forward to continuing to work with global industry peers to explore new opportunities, meet new challenges, and create a better future for the pharmaceutical and healthcare industry in Central Asia.
